FR2200013B1 - - Google Patents

Info

Publication number
FR2200013B1
FR2200013B1 FR7334501A FR7334501A FR2200013B1 FR 2200013 B1 FR2200013 B1 FR 2200013B1 FR 7334501 A FR7334501 A FR 7334501A FR 7334501 A FR7334501 A FR 7334501A FR 2200013 B1 FR2200013 B1 FR 2200013B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7334501A
Other versions
FR2200013A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2200013A1 publication Critical patent/FR2200013A1/fr
Application granted granted Critical
Publication of FR2200013B1 publication Critical patent/FR2200013B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FR7334501A 1972-09-26 1973-09-26 Expired FR2200013B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19722247187 DE2247187A1 (de) 1972-09-26 1972-09-26 Imidazolylessigsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
FR2200013A1 FR2200013A1 (fr) 1974-04-19
FR2200013B1 true FR2200013B1 (fr) 1977-09-09

Family

ID=5857425

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7334501A Expired FR2200013B1 (fr) 1972-09-26 1973-09-26

Country Status (13)

Country Link
US (1) US3950354A (fr)
JP (2) JPS584023B2 (fr)
AT (1) AT324326B (fr)
BE (1) BE805210A (fr)
CA (1) CA979898A (fr)
CH (2) CH593944A5 (fr)
DE (1) DE2247187A1 (fr)
FR (1) FR2200013B1 (fr)
GB (1) GB1402693A (fr)
IL (1) IL43298A (fr)
LU (1) LU68476A1 (fr)
NL (1) NL7313272A (fr)
PL (2) PL95785B1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050256130A1 (en) * 2002-06-12 2005-11-17 Chemocentryx, Inc. Substituted piperazines
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
CN1867336B (zh) * 2002-06-12 2010-05-12 凯莫森特里克斯股份有限公司 1-芳基-4-取代的哌嗪衍生物及其制药用途
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
US7435831B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
AU2005219438B2 (en) * 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU60908A1 (fr) * 1969-05-21 1970-07-16

Also Published As

Publication number Publication date
PL95785B1 (pl) 1977-11-30
JPS4969668A (fr) 1974-07-05
CH599194A5 (fr) 1978-05-12
DE2247187A1 (de) 1974-03-28
AT324326B (de) 1975-08-25
CA979898A (en) 1975-12-16
NL7313272A (fr) 1974-03-28
JPS584023B2 (ja) 1983-01-24
IL43298A (en) 1977-02-28
US3950354A (en) 1976-04-13
IL43298A0 (en) 1973-11-28
JPS4969811A (fr) 1974-07-05
BE805210A (fr) 1974-03-25
GB1402693A (en) 1975-08-13
PL91055B1 (fr) 1977-02-28
LU68476A1 (fr) 1973-12-07
FR2200013A1 (fr) 1974-04-19
CH593944A5 (fr) 1977-12-30

Similar Documents

Publication Publication Date Title
AR200588A1 (fr)
FR2200013B1 (fr)
JPS4998802A (fr)
JPS5723996Y2 (fr)
JPS4933214U (fr)
JPS4975975A (fr)
JPS4957792A (fr)
JPS498754Y1 (fr)
CS152936B1 (fr)
JPS4947061U (fr)
JPS4985510U (fr)
JPS4961851U (fr)
JPS4955378U (fr)
JPS4985770A (fr)
CH582659A5 (fr)
CH573507B5 (fr)
CH559395A5 (fr)
CH559156A5 (fr)
CH557922A (fr)
CH352973A4 (fr)
CH1675772A4 (fr)
CH571135A5 (fr)
CH578026A5 (fr)
CH576958A5 (fr)
CH576839A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse